Study title: Open-label, Randomized, Dose Ranging Study of Three Different Doses of Ritonavir in Combination with 3TC+d4T in Children Infected with HIV
Type of medicine: Centrally authorised medicines | |||||
Therapeutic area: Virus Diseases | |||||
Brands: Please see report, Please see report | |||||
MAH holders: Please see report, Please see report, Please see report | |||||
Assessment: | |||||
Active substance: ritonavir | |||||
ATC code: J05AE03 | |||||
Document link: | |||||
Document date: 2011-09-13 | |||||
Study number: W97-225 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | Y | Y | - |